Daily startup and blockchain data-wiki with interviews, Q&A's & discussions about funding rounds & investors.

RaisedToday moderators manually update and approve wiki edits - check back every 1-2h for approved submissions.

Contributed by laura998

Relay Therapeutics

3 Disclosed Funding Rounds $520,000,000

0 Participating Investments


Therapeutics, Health Care, Biotechnology

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Cambridge, Massachusetts, United States, North America (US)

Organizations in Cambridge in Therapeutics,
Organizations in Cambridge in Health Care,
Organizations in Cambridge in Biotechnology,
Organizations in Massachusetts in Therapeutics,
Organizations in Massachusetts in Health Care,
Organizations in Massachusetts in Biotechnology,
Organizations in United States in Therapeutics,
Organizations in United States in Health Care,
Organizations in United States in Biotechnology,
Organizations in North America in Therapeutics,
Organizations in North America in Health Care,
Organizations in North America in Biotechnology

Investors in Cambridge in Therapeutics,
Investors in Cambridge in Health Care,
Investors in Cambridge in Biotechnology,
Investors in Massachusetts in Therapeutics,
Investors in Massachusetts in Health Care,
Investors in Massachusetts in Biotechnology,
Investors in United States in Therapeutics,
Investors in United States in Health Care,
Investors in United States in Biotechnology,
Investors in North America in Therapeutics,
Investors in North America in Health Care,
Investors in North America in Biotechnology

Greater Boston Area (0 Investors) (0 Startups), New England (0 Investors) (0 Startups), East Coast (0 Investors) (0 Startups), Northeastern US (0 Investors) (0 Startups)

Founded date 01, 2016

Founders Matthew Jacobson, Dorothee Kern, David E. Shaw, Mark Murcko

Operating Status Active

Funding Stage IPO

Last Funding Type Series C

Company Type For Profit


Twitter Link

LinkedIN Link

Wikipedia Link

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.The company's platform detects and characterizes interactions that occur anywhere on a protein and combines computational methods with experimental approaches across the fields of structural biology, biophysics and chemistry, enabling pharmaceutical companies to solve and design therapies against complex diseases like cancer and others.

Date Round Raised Lead
December, 20, 2018 Series C $400,000,000 SoftBank Vision Fund
December, 14, 2017 Series B $63,000,000 Biotechnology Value Fund
September, 14, 2016 Series A $57,000,000 Third Rock Ventures

Relay Therapeutics Investors (18)

Investor Lead? Round Participating Raise Date Partners
Foresite Capital No Series C $400,000,000 December, 20, 2018 -------
EcoR1 Capital No Series C $400,000,000 December, 20, 2018 -------
Tavistock Group No Series C $400,000,000 December, 20, 2018 -------
SoftBank Vision Fund Yes Series C $400,000,000 December, 20, 2018 -------
Alexandria Venture No Series C $400,000,000 December, 20, 2018 -------
Perceptive Advisors No Series C $400,000,000 December, 20, 2018 -------
Casdin Capital No Series C $400,000,000 December, 20, 2018 -------
D. E. Shaw Research No Series C $400,000,000 December, 20, 2018 -------
GV No Series C $400,000,000 December, 20, 2018 -------
Biotechnology Value Fund No Series C $400,000,000 December, 20, 2018 -------
Third Rock Ventures No Series B $63,000,000 December, 14, 2017 -------
Section 32 No Series B $63,000,000 December, 14, 2017 -------
EcoR1 Capital No Series B $63,000,000 December, 14, 2017 -------
Biotechnology Value Fund Yes Series B $63,000,000 December, 14, 2017 -------
Casdin Capital No Series B $63,000,000 December, 14, 2017 -------
GV No Series B $63,000,000 December, 14, 2017 -------
Alexandria Venture No Series B $63,000,000 December, 14, 2017 -------
Third Rock Ventures Yes Series A $57,000,000 September, 14, 2016 -------